Dr. Jason Hafron

Dr. Jason Hafron, a urologic oncologist and chief medical officer at Solaris Health, dives into the shifting landscape of prostate cancer screening. He discusses the limitations of traditional PSA tests and introduces innovative blood-based biomarkers like IsoPSA and 4Kscore. These advancements promise to enhance diagnosis and minimize unnecessary biopsies. Dr. Hafron also explores the potential of artificial intelligence to refine risk assessments and personalize patient management, showcasing a future where precision in prostate cancer detection is within reach.